Activation of the adenosine A2A receptor exacerbates experimental autoimmune neuritis in Lewis rats in association with enhanced humoral immunity

[1]  T. Kurosaki,et al.  Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4. , 2014, Immunity.

[2]  A. Ballesteros-Tato.  Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases. , 2014, Immunotherapy.

[3]  H. Kaplan,et al.  Anti-Inflammatory or Proinflammatory Effect of an Adenosine Receptor Agonist on the Th17 Autoimmune Response Is Inflammatory Environment–Dependent , 2014, The Journal of Immunology.

[4]  S. Crotty.  T follicular helper cell differentiation, function, and roles in disease. , 2014, Immunity.

[5]  C. Wessig,et al.  FoxP3+ Regulatory T Cells Determine Disease Severity in Rodent Models of Inflammatory Neuropathies , 2014, PloS one.

[6]  B. Jacobs,et al.  Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis , 2014, Nature Reviews Neurology.

[7]  L. Yue,et al.  Therapeutic potential of atorvastatin-modified dendritic cells in experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells and NKR-P1+ cells , 2014, Journal of Neuroimmunology.

[8]  E. Shevach.  Application of IL-2 therapy to target T regulatory cell function. , 2012, Trends in immunology.

[9]  Jiang-Fan Chen,et al.  Genetic inactivation of the adenosine A2A receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis , 2012, Journal of neurochemistry.

[10]  M. Bynoe,et al.  A2A Adenosine Receptor Signaling in Lymphocytes and the Central Nervous System Regulates Inflammation during Experimental Autoimmune Encephalomyelitis , 2012, The Journal of Immunology.

[11]  T. Randall,et al.  Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. , 2012, Immunity.

[12]  Lihua Wang,et al.  Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity , 2012, European journal of immunology.

[13]  J. Eichberg,et al.  Isolation, Purification and Verification of Peripheral Nerve Myelin Derived from Bovine Cauda Equina , 2012 .

[14]  Jeffrey A. Diamond,et al.  STAT5 is a potent negative regulator of TFH cell differentiation , 2012, The Journal of experimental medicine.

[15]  M. Croft,et al.  B Cell-Specific Expression of B7-2 Is Required for Follicular Th Cell Function in Response to Vaccinia Virus , 2011, The Journal of Immunology.

[16]  T. Palmer,et al.  Anti-Inflammatory and Immunosuppressive Effects of the A2A Adenosine Receptor , 2011, TheScientificWorldJournal.

[17]  D. Campbell,et al.  Phenotypical and functional specialization of FOXP3+ regulatory T cells , 2011, Nature Reviews Immunology.

[18]  B. Hall,et al.  Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis , 2010, Journal of Neuroimmunology.

[19]  T. Malek,et al.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity. , 2010, Immunity.

[20]  F. Shi,et al.  Expansion of regulatory T cells via IL‐2/anti‐IL‐2 mAb complexes suppresses experimental myasthenia , 2010, European journal of immunology.

[21]  J. Qian,et al.  Activation of adenosine A2A receptor attenuates inflammatory response in a rat model of small-for-size liver transplantation. , 2010, Transplantation proceedings.

[22]  Bo Sun,et al.  MMP-mediated cleavage of beta-dystroglycan in myelin sheath is involved in autoimmune neuritis. , 2010, Biochemical and biophysical research communications.

[23]  W. Duan,et al.  Adenosine A2A receptor deficiency exacerbates white matter lesions and cognitive deficits induced by chronic cerebral hypoperfusion in mice , 2009, Journal of the Neurological Sciences.

[24]  J. Sprent,et al.  In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression , 2009, The Journal of experimental medicine.

[25]  J. Wilson,et al.  A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence , 2009, Mucosal Immunology.

[26]  H. Schluesener,et al.  Distribution of Foxp3+ T-regulatory cells in experimental autoimmune neuritis rats , 2009, Experimental Neurology.

[27]  S. Jalkanen,et al.  CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis , 2008, Proceedings of the National Academy of Sciences.

[28]  J. Bluestone,et al.  Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. , 2008, Immunity.

[29]  Wei Zhu,et al.  B cells play a cooperative role via CD40L–CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats , 2007, Neurobiology of Disease.

[30]  Courtney M. Lappas,et al.  Cutting Edge: Critical Role for A2A Adenosine Receptors in the T Cell-Mediated Regulation of Colitis1 , 2006, The Journal of Immunology.

[31]  Pál Pacher,et al.  Adenosine receptors: therapeutic aspects for inflammatory and immune diseases , 2006, Nature Reviews Drug Discovery.

[32]  K. Jacobson,et al.  Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. , 2005, Blood.

[33]  M. Moskowitz,et al.  Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury , 2004, Nature Medicine.

[34]  Ethan M. Shevach,et al.  Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function , 2004, The Journal of Immunology.

[35]  R. Gold,et al.  Animal models of immune-mediated neuropathies , 2002, Current opinion in neurology.

[36]  M. Moskowitz,et al.  A2A Adenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice , 1999, The Journal of Neuroscience.

[37]  Kendall A. Smith,et al.  Interleukin‐2 Deficient Mice: A New Model to Study Autoimmunity and Self‐Tolerance , 1995, Immunological reviews.

[38]  Jie Zhu,et al.  The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1 , 1994, Journal of the Neurological Sciences.

[39]  W. Norton,et al.  MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION 1 , 1973, Journal of neurochemistry.

[40]  Y. Liu,et al.  Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells. , 2011, Cellular immunology.

[41]  J. Devaux,et al.  Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis. , 2009, Brain : a journal of neurology.

[42]  M. Horton,et al.  A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. , 2008, Blood.